You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 3
  • 1025 Revisiting the Rotterdam regime in 2021: the impact of cisplatin and oral etoposide in refractory ovarian cancer in the era of great antiemetics

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
1025 Revisiting the Rotterdam regime in 2021: the impact of cisplatin and oral etoposide in refractory ovarian cancer in the era of great antiemetics
Free

 

Online download statistics by month:

Online download statistics by month: October 2021 to October 2024

AbstractFullPdf
Oct 20215709
Nov 202157012
Dec 20211406
Jan 20229805
Feb 20223000
Mar 20223202
Apr 20224106
May 20227205
Jun 20224604
Jul 20225801
Aug 20226405
Sep 20226608
Oct 20221803
Nov 20224602
Dec 20221804
Jan 20232704
Feb 20232000
Mar 20232102
Apr 20231401
May 2023600
Jun 20232001
Jul 20232105
Aug 20232803
Sep 20233001
Oct 20231401
Nov 20232002
Dec 20234900
Jan 20241200
Feb 20242003
Mar 20241801
Apr 20243005
May 20242002
Jun 20244602
Jul 20243804
Aug 20241905
Sep 20243907
Oct 2024801
Total12370122